Caitlin Saint Aubin, MD
Obstetrics & Gynecology · Providence, RINPI 1285834119
Payments from drug & device makers
What this record shows
28 manufacturers reported payments, led by AbbVie at 55.0% of the total. Reporting peaked in 2023 at $2,313 and has fallen 70.5% since, to $683 in 2025. Among obstetrics & gynecology clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 125 payments — averaging $40.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Exeltis, USA Inc.$505
- Sage Therapeutics, LLC$254
- Myovant Sciences Inc.$200
- Bayer$159
- Coopersurgical, Inc.$140
- plus $1K from 22 others
What the payments were for
- Speaking & faculty fees$2,50050%
- Food & beverage$2,52050%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 16 | $2,759 |
| Exeltis, USA Inc. | 17 | $505 |
| Sage Therapeutics, LLC | 12 | $254 |
| Myovant Sciences Inc. | 12 | $200 |
| Bayer | 8 | $159 |
| Coopersurgical, Inc. | 6 | $140 |
| Daiichi Sankyo Inc. | 5 | $119 |
| Mylan Pharmaceuticals Inc. | 6 | $111 |
| Shield Therapeutics Inc | 5 | $87 |
| Mayne Pharma Commercial LLC | 5 | $85 |
| Agile Therapeutics, Inc. | 3 | $67 |
| Evofem Biosciences, Inc. | 4 | $65 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Pfizer | 3 | $57 |
| Therapeuticsmd, Inc. | 4 | $56 |
| Organon | 2 | $42 |
| Merck | 2 | $30 |
| Dexcom, Inc. | 1 | $26 |
| Roche Diagnostics Corporation | 2 | $26 |
| Scynexis, Inc. | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| BD | 1 | $19 |
| Boston Scientific | 1 | $19 |
| Medicem Inc. | 1 | $13 |
| Avion Pharmaceuticals | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Slynd$145
How this compares
$5,020 in reported general payments places this provider in the 90th percentile of 139 obstetrics & gynecology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 22 | $893 |
| ValacyclovirValacyclovir Hcl | 20 | $273 |
| NyliaNorethindrone-Ethin. Estradiol | 11 | $45 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Providence
- Warren HuberProvidence$50K
- Lisa BoyleProvidence$30K
- Renee EgerProvidence$24K
- Gary WhartonProvidence$22K
- Christine FoleyProvidence$21K
- Cara MathewsProvidence$21K
- Michael BeitleProvidence$9K
- Ogechukwu EzikeProvidence$7K
- Beata DizoglioProvidence$6K
- Michele GangeProvidence$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.